Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development and manufacturing of injectable pharmaceuticals, focusing on high-quality, cost-effective solutions for healthcare providers. With a strong operational presence across North America, Sagent Pharmaceuticals offers a diverse portfolio of products, including generic and specialty injectables that cater to various therapeutic areas. Their commitment to quality and innovation has earned them a solid market position, recognised for their unique approach to sterile injectable manufacturing. Notable achievements include a robust pipeline of products and strategic partnerships that enhance their capabilities in delivering essential medications. Sagent Pharmaceuticals continues to prioritise patient safety and efficacy, making significant strides in the ever-evolving pharmaceutical landscape.
DitchCarbon Score
How does Sagent Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sagent Pharmaceuticals, Inc.'s score of 13 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sagent Pharmaceuticals, Inc.'s reported carbon emissions
Sagent Pharmaceuticals, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As the pharmaceutical industry increasingly focuses on sustainability, Sagent Pharmaceuticals may need to establish clear climate commitments to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sagent Pharmaceuticals, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
